Trial Profile
A phase 2 study to evaluate the safety, tolerability, and activity of fontolizumab in subjects with active rheumatoid arthritis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Fontolizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors PDL BioPharma
- 21 Aug 2006 Status change
- 27 Mar 2006 New trial record.